[Calcimimmetic and calcilytics: new perspectives of correction of abnormal parathormone (PTH) secretion].
D000814:Aniline Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D002118:Calcium / Q000819:agonists*; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D000069449:Cinacalcet; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy*; D009281:Naphthalenes / Q000494:pharmacology / Q000627:therapeutic use*; D010627:Phenethylamines; D011437:Propylamines
D000814:Aniline Compounds; D002121:Calcium Channel Blockers; C107873:N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine; C436740:N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine; D009281:Naphthalenes; D010627:Phenethylamines; D011437:Propylamines; D002118:Calcium; D000069449:Cinacalcet
Kalcymimetyki i kalcylityki: nowe perspektywy korekcji zaburzonej sekrecji parathormonu (PTH).